Pascal Touchon

Pascal Touchon serves as Chairman of the Board and President and CEO at Atara Biotherapeutics since June 2019, leading a company focused on allogeneic T-cell immunotherapy for serious diseases. Additionally, Pascal Touchon is a current member of the Board of Directors at Ipsen, contributing to the Audit, Nomination, and Innovation Development Committees, and serves as a Special Advisor at JEITO. Previous roles include Board member positions at Cogen Therapeutics and Navigate Biopharma Services, along with significant leadership roles at Novartis, including SVP Global Head of Cell & Gene and SVP for Strategy, Business Development & Licensing. Extensive experience also includes senior executive positions at Servier, where Pascal Touchon directed business development and managed commercial operations across multiple regions. Educational qualifications include an MBA from INSEAD and a Doctor of Veterinary Medicine from Université Paul Sabatier Toulouse III.